US Stock MarketDetailed Quotes

BCAX Bicara Therapeutics

Watchlist
  • 20.960
  • +0.510+2.49%
Close Nov 27 16:00 ET
  • 20.960
  • 0.0000.00%
Post 16:00 ET
1.14BMarket Cap-19176P/E (TTM)

Bicara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bicara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

Bicara Therapeutics Earnings Reports

  • Bicara Therapeutics | 10-Q: Quarterly report

    Nov 12 16:09 ET

  • Bicara Therapeutics | 8-K: Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 12 13:44 ET

    • Analysis

    Analyst Rating

    Updated: Nov 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+1.25%
    Recent IPOs
    Recent IPOs
    Intraday-1.13%